Furthermore, we detected—for the first time—significantly higher levels of plasma NGAL in the acute and subacute model, which have also been shown in HUS patients with renal dysfunction (61), but to our knowledge have not been examined in murine models of HUS. This evidence concerns the gene LCN2 and hemolytic-uremic syndrome.